Status:
COMPLETED
Neuropathic Pain in Psoriatic Arthritis
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Pathogenesis of inflammatory diseases is suitable for eliciting neuropathic pain. The aim of this study is to evaluate the frequency of NP among PsA patients and relationship between disease activity,...
Detailed Description
Neuropathic pain (NP) is the pain arising from a primary lesion or a dysfunction of nervous system. NP can affect central or peripheral nervous system and can be caused by numerous factors such as inf...
Eligibility Criteria
Inclusion
- being aged≥18
- being diagnosed PSA according to CASPAR criteria
Exclusion
- additional conditions that could cause neuropathic pain (e.g. radiculopathy, polyneuropathy, depression, fibromyalgia)
- history of fracture or surgery
- endocrinopathies that could cause neuropathic pain (e.g. DM)
- malignancy
Key Trial Info
Start Date :
January 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2022
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05223049
Start Date
January 22 2022
End Date
March 15 2022
Last Update
October 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakif University
Istanbul, Fatih, Turkey (Türkiye), 34093